Robert J.  Decker net worth and biography

Robert Decker Biography and Net Worth

Robert J. Decker holds the position of Chief Accounting Officer of Johnson & Johnson.

Mr. Decker received an undergraduate degree from Rider University.

What is Robert J. Decker's net worth?

The estimated net worth of Robert J. Decker is at least $4.25 million as of February 25th, 2025. Mr. Decker owns 21,001 shares of Johnson & Johnson stock worth more than $4,247,242 as of December 4th. This net worth estimate does not reflect any other investments that Mr. Decker may own. Learn More about Robert J. Decker's net worth.

How old is Robert J. Decker?

Mr. Decker is currently 52 years old. There are 6 older executives and no younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Dr. John C. Reed M.D., Ph.D., Executive Vice President of Innovative Medicine, R&D, who is 66 years old. Learn More on Robert J. Decker's age.

How do I contact Robert J. Decker?

The corporate mailing address for Mr. Decker and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at [email protected]. Learn More on Robert J. Decker's contact information.

Has Robert J. Decker been buying or selling shares of Johnson & Johnson?

Robert J. Decker has not been actively trading shares of Johnson & Johnson over the course of the past ninety days. Most recently, Robert J. Decker sold 6,999 shares of the business's stock in a transaction on Tuesday, February 25th. The shares were sold at an average price of $165.88, for a transaction totalling $1,160,994.12. Following the completion of the sale, the vice president now directly owns 21,001 shares of the company's stock, valued at $3,483,645.88. Learn More on Robert J. Decker's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Chairman), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Timothy Schmid (EVP, Worldwide Chairman, MedTech), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (EVP), Jennifer Taubert (EVP), Mark Weinberger (Director), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, Johnson & Johnson insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $147,220.00. During the last year, insiders at the sold shares 3 times. They sold a total of 63,873 shares worth more than $11,265,031.08. The most recent insider tranaction occured on September, 4th when EVP Jennifer L Taubert sold 56,471 shares worth more than $10,041,108.51. Insiders at Johnson & Johnson own 0.2% of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 9/4/2025.

Robert J. Decker Insider Trading History at Johnson & Johnson

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/25/2025Sell6,999$165.88$1,160,994.1221,001View SEC Filing Icon  
8/30/2024Sell5,635$165.06$930,113.1018,973View SEC Filing Icon  
11/18/2022Sell16,928$175.00$2,962,400.0015,473View SEC Filing Icon  
5/26/2022Sell8,462$180.00$1,523,160.0015,473View SEC Filing Icon  
12/7/2021Sell5,000$163.21$816,050.00View SEC Filing Icon  
See Full Table

Robert J. Decker Buying and Selling Activity at Johnson & Johnson

This chart shows Robert J Decker's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Read More

Today's Range

Now: $202.24
Low: $201.71
High: $204.86

50 Day Range

MA: $193.61
Low: $179.69
High: $207.75

2 Week Range

Now: $202.24
Low: $140.68
High: $207.81

Volume

9,048,965 shs

Average Volume

8,983,565 shs

Market Capitalization

$487.25 billion

P/E Ratio

19.52

Dividend Yield

2.53%

Beta

0.36